- Home
- Publications
- Publication Search
- Publication Details
Title
LOXL2 in cancer: regulation, downstream effectors and novel roles
Authors
Keywords
LOXL2, Oxidation, Regulation, Cytoskeleton, Cancer
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1874, Issue 2, Pages 188435
Publisher
Elsevier BV
Online
2020-09-23
DOI
10.1016/j.bbcan.2020.188435
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-Talk Between the Tumor Microenvironment, Extracellular Matrix, and Cell Metabolism in Cancer
- (2020) Mona Nazemi et al. Frontiers in Oncology
- LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
- (2020) Olga Almacellas-Rabaiget et al. CANCER LETTERS
- Inhibition of LOXL2 Enhances the Radiosensitivity of Castration-Resistant Prostate Cancer Cells Associated with the Reversal of the EMT Process
- (2019) Peng Xie et al. Biomed Research International
- Glycosylation in health and disease
- (2019) Colin Reily et al. Nature Reviews Nephrology
- Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB
- (2019) Faranak Mahjour et al. Oncogenesis
- Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
- (2019) Chunying Wang et al. NEOPLASIA
- Extracellular ATP promotes breast cancer invasion and epithelial‐mesenchymal transition via hypoxia‐inducible factor 2α signaling
- (2019) Hui Yang et al. CANCER SCIENCE
- LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion
- (2019) Xiu-Hui Zhan et al. CANCER RESEARCH
- Correction: LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
- (2019) Holly E. Barker et al. CANCER RESEARCH
- LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells
- (2019) J. P. Cebrià-Costa et al. ONCOGENE
- A novel splice variant of LOXL2 promotes progression of human papillomavirus–negative head and neck squamous cell carcinoma
- (2019) Chao Liu et al. CANCER
- LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
- (2019) Jing Tian et al. OncoTargets and Therapy
- Identification and characterization of the promoter of cancer-related gene LOXL2
- (2019) Xin Liu et al. EXPERIMENTAL CELL RESEARCH
- MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer
- (2018) Ming-fan Ye et al. BIOMEDICINE & PHARMACOTHERAPY
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
- (2018) Jiwoon Choi et al. Gut and Liver
- Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation
- (2018) Sifan Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Recombinant Human Lysyl Oxidase-like 2 Secreted from Human Embryonic Kidney Cells Displays Complex and Acidic Glycans at All Three N-Linked Glycosylation Sites
- (2018) Eden P. Go et al. JOURNAL OF PROTEOME RESEARCH
- Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state
- (2018) Xi Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2
- (2018) Philipp Neumann et al. Nature Communications
- Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma
- (2018) Yan Qu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease
- (2018) Andrew J. Muir et al. HEPATOLOGY
- Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity
- (2018) Kazushi Okada et al. BIOCHEMISTRY
- LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
- (2018) Bing Shao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis
- (2018) Heidi Schilter et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Proteolytic processing of lysyl oxidase–like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV
- (2017) Alberto J. López-Jiménez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis
- (2017) Ying Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment
- (2017) Meili Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2)
- (2017) Martin W. Rowbottom et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation
- (2017) Li Ma et al. MOLECULAR CELL
- A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of MetastaticKRASMutant Colorectal Adenocarcinoma
- (2017) J. Randolph Hecht et al. ONCOLOGIST
- A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma
- (2017) Al B. Benson et al. ONCOLOGIST
- Role of protein glycosylation in cancer metastasis
- (2017) Leticia Oliveira-Ferrer et al. SEMINARS IN CANCER BIOLOGY
- Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX
- (2017) John H. Hutchinson et al. ACS Medicinal Chemistry Letters
- Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
- (2017) Joan Chang et al. Oncotarget
- A three-gene signature from protein-protein interaction network of LOXL2 - and actin-related proteins for esophageal squamous cell carcinoma prognosis
- (2017) Xiu-hui Zhan et al. Cancer Medicine
- LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway
- (2017) Eva P. Cuevas et al. Scientific Reports
- Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer
- (2016) Ping Zhan et al. Clinical Respiratory Journal
- TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking
- (2016) Zakaria Ezzoukhry et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone H3
- (2016) Nicolás Herranz et al. FEBS Journal
- SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
- (2016) Ying Zhu et al. HUMAN PATHOLOGY
- Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis
- (2016) Kazuto Kamikawaji et al. JOURNAL OF HUMAN GENETICS
- ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
- (2016) D H Peng et al. ONCOGENE
- The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
- (2016) C Wilson et al. ONCOGENE
- Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth
- (2016) Keren Weidenfeld et al. Oncotarget
- LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival
- (2015) S. Torres et al. CLINICAL CANCER RESEARCH
- Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression
- (2015) A. Martin et al. EMBO JOURNAL
- Tumour-suppressivemicroRNA-29sdirectly regulateLOXL2expression and inhibit cancer cell migration and invasion in renal cell carcinoma
- (2015) Rika Nishikawa et al. FEBS LETTERS
- Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma
- (2015) KEIKO MIZUNO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma
- (2015) Ichiro Fukumoto et al. JOURNAL OF HUMAN GENETICS
- Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma
- (2014) Guo-Qing Lv et al. Biochemistry and Cell Biology
- Human lysyl oxidase-like 2
- (2014) Hee-Jung Moon et al. BIOORGANIC CHEMISTRY
- Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
- (2014) Hiroaki Kasashima et al. CANCER LETTERS
- Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1
- (2014) Boh-Ram Kim et al. CELLULAR SIGNALLING
- 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma
- (2014) Jing Xu et al. DIGESTIVE AND LIVER DISEASE
- Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma
- (2014) Carmen Chak-Lui Wong et al. HEPATOLOGY
- LOXL2 Status Correlates with Tumor Stage and Regulates Integrin Levels to Promote Tumor Progression in ccRCC
- (2014) H. Hase et al. MOLECULAR CANCER RESEARCH
- Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization
- (2014) G Canesin et al. ONCOGENE
- Exploration of Potential Roles of a New LOXL2 Splicing Variant Using Network Knowledge in Esophageal Squamous Cell Carcinoma
- (2014) Bing-Li Wu et al. TheScientificWorldJOURNAL
- LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
- (2014) E. P. Cuevas et al. Biology Open
- LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients
- (2013) Sung Gwe Ahn et al. BREAST CANCER RESEARCH AND TREATMENT
- Post-translational Modifications of Recombinant Human Lysyl Oxidase-like 2 (rhLOXL2) Secreted fromDrosophilaS2 Cells
- (2013) Li Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasivein Vitro
- (2013) Hee-Jung Moon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling
- (2013) H. E. Barker et al. MOLECULAR CANCER RESEARCH
- Regulation of Heterochromatin Transcription by Snail1/LOXL2 during Epithelial-to-Mesenchymal Transition
- (2013) Alba Millanes-Romero et al. MOLECULAR CELL
- Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells
- (2012) Zu-Yau Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
- (2012) W. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
- (2011) H. E. Barker et al. CANCER RESEARCH
- Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
- (2011) Gema Moreno-Bueno et al. EMBO Molecular Medicine
- Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase–like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma
- (2011) Tian-Yu Li et al. HUMAN PATHOLOGY
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
- (2011) Héctor Peinado et al. SEMINARS IN CANCER BIOLOGY
- Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2
- (2010) Vera Brekhman et al. FASEB JOURNAL
- Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
- (2010) Hector M. Rodriguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysyl oxidase expression and inhibition in uveal melanoma
- (2010) Daniel A. Abourbih et al. MELANOMA RESEARCH
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway
- (2009) Liang Peng et al. CARCINOGENESIS
- The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia
- (2009) Ruth Schietke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
- (2009) Mo Chen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Differential expression of the LOX family genes in human colorectal adenocarcinomas
- (2009) Kim ONCOLOGY REPORTS
- Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
- (2008) H. Peinado et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now